Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies

NCT03056339 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

B-Lymphoid Malignancies
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Non-hodgkin Lymphoma

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Mesna
BIOLOGICAL: iC9/CAR.19/IL15-Transduced CB-NK Cells
DRUG: AP1903

Sponsor

M.D. Anderson Cancer Center